Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2019 Earnings Conference Call February 27, 2020 4:30 PM ET
Company Participants
David Arrington - Vice President of Investor Relations & Corporate Affairs
Dennis Lanfear - Chief Executive Officer
Jean Viret - Chief Financial Officer
Vince Anicett - Chief Operating Officer
Thomas Fitzpatrick - Chief Legal Officer
Conference Call Participants
Mohit Bansal - Citigroup
Douglas Tsao - H.C. Wainwright
Mike Wolff - Baird
Ekaterina Knyazkova - JP Morgan Chase & Co
Salim Syed - Mizuho Securities
Michael Okunewitch - Maxim Group
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Coherus BioSciences 2019 Fourth Quarter Earnings Conference Call. My name is May and I will be your conference operator for the call today. At this time, all participants are in a listen-only mode. And as a reminder, this conference call is being recorded.
I would now like to turn the call over to David Arrington, Vice President of Investor Relations and Corporate Affairs. Please go ahead.
David Arrington
Thank you, May, and good afternoon everyone. After close of market today, we issued a press release on our fourth quarter and year-end financial results. This release can be found on the Coherus BioSciences website. Joining me for today's call will be Denny Lanfear, Coherus' CEO; Dr. Jean Viret, Chief Financial Officer; Vince Anicett, Chief Operating Officer; and Tom Fitzpatrick, Chief Legal Officer.
Before we begin our formal remarks, I would like to remind you that we will be making forward-looking statements with respect to product development plans, all of which involve certain assumptions, risks and uncertainties that are beyond our control and could cause actual results to differ from these statements. A description of these risks can be found on our most recent filings with the SEC.
In addition, Coherus BioSciences does not
- Read more current CHRS analysis and news
- View all earnings call transcripts